Sangamo Therapeutics (SGMOQ) Non-Current Deferred Revenue (2009 - 2026)
Sangamo Therapeutics' Non-Current Deferred Revenue was $5.87 million in Q1 2026, unchanged from $5.87 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Non-Current Deferred Revenue (2009 - 2026) Analysis & Trends
From Q1 2012 onward, Sangamo Therapeutics has reported Non-Current Deferred Revenue for 51 quarters.
- Non-Current Deferred Revenue shows a five-year compound annual growth rate of -52.6% (FY2020 to FY2025).
- In earlier years, Non-Current Deferred Revenue was $5.87 million in FY2024, $109.38 million in FY2022 (-34.4%) and $166.78 million in FY2021 (-31.9%).
- Quarterly Non-Current Deferred Revenue has moved between $1.82 million (Q1 2023) and $201.25 million (Q2 2021) over five years.
- Across the past five years, year-over-year decline in Non-Current Deferred Revenue ran from 0.0% in Q1 2026 to 98.8% in Q1 2023.
- Per Business Quant data, SGMOQ's Non-Current Deferred Revenue in the three quarters before Q1 2026 was $5.87 million (Q4 2025), $5.87 million (Q3 2025) and $5.87 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Sangamo Therapeutics | 45.57 Mn | -70.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.87 Mn |
| Dec 31, 2025 | 5.87 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Mar 31, 2025 | 5.87 Mn |
| Dec 31, 2024 | 5.87 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 109.38 Mn |
| Sep 30, 2022 | 115.64 Mn |
| Jun 30, 2022 | 129.92 Mn |
| Mar 31, 2022 | 150.70 Mn |
| Dec 31, 2021 | 166.78 Mn |
| Sep 30, 2021 | 183.94 Mn |
| Jun 30, 2021 | 201.25 Mn |
| Mar 31, 2021 | 222.28 Mn |
| Dec 31, 2020 | 245.05 Mn |
| Sep 30, 2020 | 267.90 Mn |
| Jun 30, 2020 | 237.64 Mn |
| Mar 31, 2020 | 75.27 Mn |
| Dec 31, 2019 | 81.43 Mn |
API Access
Sangamo Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();